The Alpine Winter Conference on Medicinal and Synthetic 91AV exposes attending scientists to cutting edge synthetic and medicinal chemistry as well as latest developments in technologies that foster innovation in drug discovery. The main target audience for this highly interdisciplinary meeting will include medicinal and synthetic chemists, as well as related drug discovery disciplines from both industry and academia as well as graduate/undergraduate students and postdocs.
The conference topics will be maintained, and the Scientific Organising Committee is preparing an adapted scientific programme, that will be announced in a few days.
For each of the below topics, a slot in the programme will be available for an oral communication selected out of the submitted abstracts. In addition, an open MedChem session on "Drug Discovery Tales" will have 5 open slots for oral communications.
The Conference topics will include:
During the conference, you will have the opportunity to listen to our three keynote lecturers:
The conference topics will be maintained, and the Scientific Organising Committee is preparing an adapted scientific programme, that will be announced in a few days.
For each of the below topics, a slot in the programme will be available for an oral communication selected out of the submitted abstracts. In addition, an open MedChem session on "Drug Discovery Tales" will have 5 open slots for oral communications.
The Conference topics will include:
- Automation and Machine Learning Applications for Medicinal 91AV
- Covalent Targeting: Innovating for the Future
- Drug Discovery Tales
- Increasing sp3 Fragment Options: Advances in the Synthesis of Small Ring Systems
- Methodologies to Understand Cellular Target Interaction
- Targeting Unstructured Proteins
- The "Catalytic Cycle" of Complex Molecule Synthesis and Methodology Development
- Understanding PK and PK/PD relationships in drug discovery - Target Mediated Drug Disposition
During the conference, you will have the opportunity to listen to our three keynote lecturers:
- Prof. Angela Koehler, MIT Koch Institute For Integrative Cancer Research, United States
- Prof. Paul Knochel, Ludwig Maximilian University, Germany
- Dr Wendy Young, MPM Capital, United States
